Your browser is no longer supported. Please, upgrade your browser.
BSTC BioSpecifics Technologies Corp. weekly Stock Chart
BioSpecifics Technologies Corp.
Index- P/E19.36 EPS (ttm)3.34 Insider Own3.00% Shs Outstand7.34M Perf Week0.12%
Market Cap463.18M Forward P/E11.23 EPS next Y5.75 Insider Trans0.00% Shs Float5.75M Perf Month-1.45%
Income24.60M PEG0.88 EPS next Q-0.05 Inst Own66.60% Short Float4.91% Perf Quarter13.73%
Sales39.70M P/S11.67 EPS this Y21.70% Inst Trans3.47% Short Ratio7.91 Perf Half Y-1.13%
Book/sh17.62 P/B3.67 EPS next Y180.49% ROA20.00% Target Price100.00 Perf Year8.59%
Cash/sh14.53 P/C4.45 EPS next 5Y22.00% ROE20.40% 52W Range42.00 - 69.73 Perf YTD13.45%
Dividend- P/FCF- EPS past 5Y38.40% ROI18.10% 52W High-6.78% Beta0.70
Dividend %- Quick Ratio36.70 Sales past 5Y22.10% Gross Margin- 52W Low54.76% ATR2.90
Employees7 Current Ratio36.70 Sales Q/Q19.80% Oper. Margin71.90% RSI (14)51.86 Volatility4.95% 3.83%
OptionableNo Debt/Eq0.00 EPS Q/Q1.50% Profit Margin61.80% Rel Volume0.16 Prev Close64.60
ShortableYes LT Debt/Eq0.00 Earnings- Payout0.00% Avg Volume35.69K Price65.00
Recom- SMA200.81% SMA503.20% SMA20012.50% Volume2,786 Change0.62%
Jul-07-20Reiterated H.C. Wainwright Buy $90 → $100
Nov-13-17Reiterated H.C. Wainwright Buy $72 → $65
Mar-08-16Initiated Rodman & Renshaw Buy $60
Jul-16-15Initiated MLV & Co Buy $76
Nov-11-14Reiterated MKM Partners Buy $38 → $46
Aug-12-14Reiterated MKM Partners Buy $28 → $38
Jan-09-14Reiterated MKM Partners Buy $24.50 → $28
Dec-09-13Reiterated MKM Partners Buy $23.50 → $24.50
Apr-05-12Initiated MKM Partners Buy $26.50
Mar-15-12Initiated Stifel Nicolaus Buy $29
Jun-15-09Initiated Hapoalim Outperform $40
Aug-11-20 12:46PM  
Aug-10-20 09:25AM  
Aug-07-20 12:30PM  
Jul-20-20 07:30AM  
Jul-15-20 10:37AM  
Jul-09-20 09:30AM  
Jul-08-20 07:31AM  
Jul-06-20 08:08AM  
Jun-26-20 11:18AM  
May-16-20 08:30AM  
May-11-20 08:05AM  
May-07-20 09:49AM  
May-05-20 08:00AM  
Apr-29-20 11:30AM  
Apr-23-20 11:33AM  
Apr-21-20 12:22PM  
Apr-20-20 09:17AM  
Apr-17-20 09:40AM  
Apr-16-20 07:27AM  
Apr-15-20 10:19AM  
Apr-10-20 04:00PM  
Apr-09-20 08:05AM  
Apr-07-20 12:00PM  
Apr-02-20 10:22AM  
Mar-30-20 01:52PM  
Mar-19-20 06:21AM  
Mar-16-20 04:01PM  
Feb-20-20 06:34AM  
Feb-14-20 05:00AM  
Feb-05-20 09:23AM  
Jan-21-20 05:56AM  
Jan-17-20 09:34AM  
Dec-24-19 09:37AM  
Dec-22-19 08:15AM  
Dec-13-19 12:38PM  
Dec-04-19 08:36AM  
Nov-22-19 07:11AM  
Nov-14-19 08:53AM  
Nov-08-19 09:25AM  
Nov-01-19 10:30AM  
Oct-31-19 02:20PM  
Oct-24-19 09:00AM  
Oct-23-19 08:01AM  
Oct-21-19 07:17AM  
Oct-17-19 09:00AM  
Oct-10-19 08:01AM  
Oct-03-19 08:49AM  
Sep-25-19 02:38PM  
Sep-13-19 08:39AM  
Sep-10-19 04:56AM  
Sep-09-19 09:50AM  
Sep-03-19 06:14AM  
Aug-26-19 08:37AM  
Aug-11-19 09:51AM  
Aug-09-19 05:15PM  
Aug-05-19 08:42AM  
Aug-01-19 10:33AM  
Jul-16-19 08:00AM  
Jul-05-19 03:59PM  
May-23-19 08:01AM  
May-16-19 04:35PM  
May-14-19 02:36PM  
May-12-19 10:00PM  
May-10-19 08:26AM  
May-02-19 02:34PM  
Apr-30-19 08:02AM  
Apr-16-19 07:17PM  
Apr-12-19 09:45AM  
Apr-09-19 10:29AM  
Apr-04-19 09:10AM  
Apr-02-19 08:22AM  
Mar-25-19 08:32AM  
Mar-22-19 08:01AM  
Mar-20-19 09:00AM  
Mar-18-19 08:01AM  
Mar-05-19 04:36PM  
Feb-21-19 11:27AM  
Feb-04-19 07:35AM  
Jan-28-19 09:32AM  
Jan-17-19 09:30AM  
Jan-16-19 10:36AM  
Jan-11-19 10:32AM  
Jan-10-19 11:00AM  
Jan-09-19 09:45AM  
Jan-07-19 12:42PM  
Jan-03-19 10:29AM  
Jan-02-19 09:25AM  
BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis, human lipoma, and uterine fibroids. The company has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wegman TobyDirectorSep 10Sale55.168,900490,924935,073Sep 10 09:22 PM
Wegman TobyDirectorSep 09Sale55.231,10060,753943,973Sep 10 09:22 PM
Schamroth MichaelDirectorSep 03Option Exercise26.4315,000396,450115,890Sep 06 03:41 PM